Novadaq Technologies (NVDQ) 12.43 $NVDQ
Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
FARO: 44.64 (-0.93), CDZI: 8.65 (-0.33), UNXL: 5.76 (+0.01), NDQ.TO: 15.30 (-0.49), CZR: 9.68 (-0.24), NVDQ: 12.43 (-0.37), UCTT: 5.66 (+0.14), REPH: 10.71 (-0.78), SANM: 21.09 (+0.40)
Novadaq Technologies (NVDQ) Strong On High Relative Volume Today
at The Street - Mon Apr 20, 9:13AM CDT
Trade-Ideas LLC identified Novadaq Technologies (NVDQ) as a strong on high relative volume candidate
NVDQ: 12.43 (-0.37)
NOVADAQ to Release First Quarter 2015 Financial Results on April 28, 2015 -- Conference Call to Follow
GlobeNewswire - Wed Apr 15, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the first quarter of 2015 after market close on Tuesday, April 28, 2015.
NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ to Participate in Upcoming Investor Conferences
GlobeNewswire - Mon Mar 23, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will participate in two upcoming investor conferences.
NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ Announces Appointment of Patrice E. Merrin to Its Board of Directors
GlobeNewswire - Mon Mar 09, 7:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that Patrice E. Merrin has been appointed to the Company's Board of Directors.
NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
5 Health Care Stocks to Trade for Breakout Gains in March
at The Street - Tue Mar 03, 6:08AM CST
Here's a technical look at five of the best breakout setups in the health care sector right now.
ZFGN: 39.06 (+0.36), DXCM: 69.28 (-1.05), EW: 140.87 (+0.39), GSK: 46.57 (-0.67), NVDQ: 12.43 (-0.37)
Novadaq Technologies' (NVDQ) CEO Arun Menawat on Q4 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 10:00PM CST
NVDQ: 12.43 (-0.37)
Novadaq reports 4Q loss
Automated Insights - Wed Feb 25, 5:39PM CST
MISSISSAUGA, Ontario (AP) _ Novadaq Technologies Inc. (NVDQ) on Wednesday reported a loss of $17.6 million in its fourth quarter.
NVDQ: 12.43 (-0.37)
Novadaq Technologies misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 3:14PM CST
NVDQ: 12.43 (-0.37)
Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 4:30PM CST
OCR: 84.52 (+3.45), ISLE: 14.97 (+0.02), CCOI: 34.54 (+0.24), LAMR: 60.38 (+0.65), RRD: 19.55 (+0.07), HFC: 38.69 (+0.50), LL: 33.86 (+0.50), ICLR: 69.24 (+1.28), CVC: 18.41 (-0.21), TDS: 27.04 (+0.53), MEMP: 16.95 (-0.16), ECA: 13.88 (+0.30), DLTR: 80.57 (-0.21), JAKK: 6.78 (unch), CHK: 14.41 (-0.16), BBG: 9.80 (-0.41), TGT: 81.34 (+0.09), FMS: 42.65 (-0.50), LOW: 73.07 (-0.17), AEE: 41.68 (+0.13), FI: 18.91 (+0.11), STRZA: 37.48 (-0.36), LAD: 102.54 (+0.04), PERI: 3.72 (-0.03), MWE: 66.82 (+0.13), CLH: 54.98 (-0.02), EV: 43.60 (+0.19), DIN: 101.32 (+0.24), STWD: 24.21 (+0.20), SMP: 41.82 (+0.04), TJX: 66.41 (+0.12), AVA: 33.51 (+0.12), RY: 65.41 (+0.06), MGA: 53.10 (-0.45), CPB: 46.11 (+0.06), BSFT: 34.73 (+0.03), EE: 38.06 (+0.14), SODA: 20.76 (+0.34), USM: 37.68 (+0.55), NVDQ: 12.43 (-0.37)
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 4.01 (-0.06), INSM: 23.12 (-0.10), RNN: 0.73 (-0.03), ZSPH: 42.50 (+1.08), RDHL: 14.61 (+0.05), ASPX: 100.79 (+0.09), ACUR: 0.75 (-0.03), XNPT: 7.42 (+0.12), SPNC: 34.65 (-0.07), CORI: 9.09 (+0.42), SAGE: 59.50 (-2.56), EBIO: 10.32 (+0.22), HAE: 42.33 (-0.21), JAZZ: 186.13 (-0.41), ICPT: 280.45 (-8.26), NVDQ: 12.43 (-0.37)
NOVADAQ to Release Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015 -- Conference Call to Follow
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce its fourth quarter and full year 2014 financial results on Wednesday, February 25, 2015.
NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ to Participate in February Investor Conferences
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in two investor conferences in February.
NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
Look Past A Sales Transition To Novadaq's Future
Stephen Simpson, CFA - at Seeking Alpha - Fri Jan 16, 3:53PM CST
NVDQ: 12.43 (-0.37)
Novadaq Tech reports preliminary results and 2015 outlook
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 1:24PM CST
NVDQ: 12.43 (-0.37)
NOVADAQ Announces Fourth Quarter 2014 Preliminary Unaudited Revenues and Issues 2015 Revenue Guidance
GlobeNewswire - Mon Jan 12, 6:30AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today preliminary unaudited revenue for the fourth quarter of 2014 and provided 2015 revenue guidance ahead of its participation at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
JPM: 62.94 (+0.63), NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 29, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that its President and Chief Executive Officer, Dr. Arun Menawat, will present an update on the Company's business at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 at 8:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, CA.
JPM: 62.94 (+0.63), NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
FARO: 44.64 (-0.93), CDZI: 8.65 (-0.33), UNXL: 5.76 (+0.01), NDQ.TO: 15.30 (-0.49), CZR: 9.68 (-0.24), NVDQ: 12.43 (-0.37), UCTT: 5.66 (+0.14), REPH: 10.71 (-0.78), SANM: 21.09 (+0.40)
Novadaq Technologies (NVDQ) Strong On High Relative Volume Today
at The Street - Mon Apr 20, 9:13AM CDT
Trade-Ideas LLC identified Novadaq Technologies (NVDQ) as a strong on high relative volume candidate
NVDQ: 12.43 (-0.37)
NOVADAQ to Release First Quarter 2015 Financial Results on April 28, 2015 -- Conference Call to Follow
GlobeNewswire - Wed Apr 15, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the first quarter of 2015 after market close on Tuesday, April 28, 2015. NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ to Participate in Upcoming Investor Conferences
GlobeNewswire - Mon Mar 23, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will participate in two upcoming investor conferences. NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ Announces Appointment of Patrice E. Merrin to Its Board of Directors
GlobeNewswire - Mon Mar 09, 7:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that Patrice E. Merrin has been appointed to the Company's Board of Directors. NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
5 Health Care Stocks to Trade for Breakout Gains in March
at The Street - Tue Mar 03, 6:08AM CST
Here's a technical look at five of the best breakout setups in the health care sector right now.
ZFGN: 39.06 (+0.36), DXCM: 69.28 (-1.05), EW: 140.87 (+0.39), GSK: 46.57 (-0.67), NVDQ: 12.43 (-0.37)
Novadaq Technologies' (NVDQ) CEO Arun Menawat on Q4 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 10:00PM CST
NVDQ: 12.43 (-0.37)
Novadaq reports 4Q loss
Automated Insights - Wed Feb 25, 5:39PM CST
MISSISSAUGA, Ontario (AP) _ Novadaq Technologies Inc. (NVDQ) on Wednesday reported a loss of $17.6 million in its fourth quarter.
NVDQ: 12.43 (-0.37)
Novadaq Technologies misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 3:14PM CST
NVDQ: 12.43 (-0.37)
Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 4:30PM CST
OCR: 84.52 (+3.45), ISLE: 14.97 (+0.02), CCOI: 34.54 (+0.24), LAMR: 60.38 (+0.65), RRD: 19.55 (+0.07), HFC: 38.69 (+0.50), LL: 33.86 (+0.50), ICLR: 69.24 (+1.28), CVC: 18.41 (-0.21), TDS: 27.04 (+0.53), MEMP: 16.95 (-0.16), ECA: 13.88 (+0.30), DLTR: 80.57 (-0.21), JAKK: 6.78 (unch), CHK: 14.41 (-0.16), BBG: 9.80 (-0.41), TGT: 81.34 (+0.09), FMS: 42.65 (-0.50), LOW: 73.07 (-0.17), AEE: 41.68 (+0.13), FI: 18.91 (+0.11), STRZA: 37.48 (-0.36), LAD: 102.54 (+0.04), PERI: 3.72 (-0.03), MWE: 66.82 (+0.13), CLH: 54.98 (-0.02), EV: 43.60 (+0.19), DIN: 101.32 (+0.24), STWD: 24.21 (+0.20), SMP: 41.82 (+0.04), TJX: 66.41 (+0.12), AVA: 33.51 (+0.12), RY: 65.41 (+0.06), MGA: 53.10 (-0.45), CPB: 46.11 (+0.06), BSFT: 34.73 (+0.03), EE: 38.06 (+0.14), SODA: 20.76 (+0.34), USM: 37.68 (+0.55), NVDQ: 12.43 (-0.37)
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 4.01 (-0.06), INSM: 23.12 (-0.10), RNN: 0.73 (-0.03), ZSPH: 42.50 (+1.08), RDHL: 14.61 (+0.05), ASPX: 100.79 (+0.09), ACUR: 0.75 (-0.03), XNPT: 7.42 (+0.12), SPNC: 34.65 (-0.07), CORI: 9.09 (+0.42), SAGE: 59.50 (-2.56), EBIO: 10.32 (+0.22), HAE: 42.33 (-0.21), JAZZ: 186.13 (-0.41), ICPT: 280.45 (-8.26), NVDQ: 12.43 (-0.37)
NOVADAQ to Release Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015 -- Conference Call to Follow
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce its fourth quarter and full year 2014 financial results on Wednesday, February 25, 2015. NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ to Participate in February Investor Conferences
GlobeNewswire - Tue Feb 10, 6:25AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in two investor conferences in February. NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
Look Past A Sales Transition To Novadaq's Future
Stephen Simpson, CFA - at Seeking Alpha - Fri Jan 16, 3:53PM CST
NVDQ: 12.43 (-0.37)
Novadaq Tech reports preliminary results and 2015 outlook
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 1:24PM CST
NVDQ: 12.43 (-0.37)
NOVADAQ Announces Fourth Quarter 2014 Preliminary Unaudited Revenues and Issues 2015 Revenue Guidance
GlobeNewswire - Mon Jan 12, 6:30AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today preliminary unaudited revenue for the fourth quarter of 2014 and provided 2015 revenue guidance ahead of its participation at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. JPM: 62.94 (+0.63), NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
NOVADAQ to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 29, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that its President and Chief Executive Officer, Dr. Arun Menawat, will present an update on the Company's business at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 at 8:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, CA. JPM: 62.94 (+0.63), NDQ.TO: 15.30 (-0.49), NVDQ: 12.43 (-0.37)
